ロード中...
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Increasing interest in repurposing the diabetic medication metformin for cancer treatment has raised important questions about the translation of promising preclinical findings to therapeutic efficacy, especially in non-diabetic patients. A significant limitation of the findings to date is the use o...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695136/ https://ncbi.nlm.nih.gov/pubmed/26172303 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|